Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.
Earnings' unreliability is one of the reasons Foolish investors often flip straight past the income statement to check the cash flow statement. In general, by taking a close look at the cash moving in and out of the business, you can better understand whether the last batch of earnings brought money into the company, or merely disguised a cash gusher with a pretty headline.
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Hill-Rom Holdings (NYSE: HRC ) , whose recent revenue and earnings are plotted below.
Top Net Payout Yield Stocks To Invest In Right Now: Helvetia Holding AG (HELN)
Helvetia Holding AG is a Switzerland-based holding company of the Helvetia Group, an internationally active, all-lines insurance service group. The Company divides its activities into country markets Switzerland, Germany, Italy, Spain and Other insurance units, which include Austria, France and the global reinsurance business, as well as the Corporate segment, which includes all the Helvetia Group activities, as well as financing companies and the Company. Helvetia Holding AG classifies its activities as life business, non-life business and other activities. The life business offers life insurance, pension plans and annuities, among others. The non-life business includes property, motor vehicle, liability and transport policies, as well as health and accidental insurance coverage. The reinsurance business, among others, is included in Other activities business. The Company operates through its branch offices and subsidiaries. Advisors' Opinion:- [By Tom Stoukas]
Helvetia Holding AG (HELN) added 3.3 percent to 412 Swiss francs. Switzerland�� fourth-biggest insurer said first-half profit rose because of increased life-insurance sales and an acquisition in France. Net income climbed to 179.5 million Swiss francs ($192 million) in the six months through June, beating the average analyst estimate of 164.4 million francs.
5 Best Integrated Utility Stocks To Buy For 2014: Cinemark Holdings Inc(CNK)
Cinemark Holdings, Inc. and its subsidiaries engage in the motion picture exhibition business. As of June 30, 2011, it operated 436 theatres with 4,983 screens in 39 states of the United States, as well as in Brazil, Mexico, and 11 other Latin American countries. The company is headquartered in Plano, Texas.
Advisors' Opinion:- [By Teresa Rivas]
Cinemark Holdings�(CNK) is climbing Tuesday, shaking off earlier weakness as the market digests its better-than-expected second quarter.
The company said it earned 62 cents a share on revenue of $717.9 million. Analysts were looking for earnings of 48 cents a share on revenue of $707.7 million.
Average ticket price increased 2.1% in the quarter, and concession revenues per patron grew 2.9%. Admissions overall were $455.7 million while concession sales were $226.5 million.
FBR�� Barton Crockett reiterated an Outperform rating and $39 price target: ��inemark’s 2Q14 earnings report was encouraging in a difficult period. Revenues beat our expectations on upside in box office per screen growth in Latin America and U.S. concession pricing. Adj. EBITDA beat because of U.S. expenses. Domestically, while Cinemark’s box office trend was in-line with our estimate, it did not feature the Imax/faith-based movie mix headwinds that resulted in underperformance at Regal Entertainment (RGC) and AMC Entertainment (AMC).��/p>
MKM Partners��� Eric Handler reiterated a Buy rating and $40 price target: ��e look for Cinemark’s shares to outperform the market following better than expected 2Q14 results.�Cinemark beat our/consensus estimates with upside to both domestic and Latin American results. Our positive view towards Cinemark reflects: (1) continued expansion potential of 100-125 screens annually in Latin America; and (2) projected increases in FCF over the next several years, which could lead to more regular dividend increases. The box office will likely remain choppy for the remainder of 2014, but we believe a strong two-year, global content cycle will begin in 2015.��/p>
5 Best Integrated Utility Stocks To Buy For 2014: Ethan Allen Interiors Inc (ETH)
Ethan Allen Interiors Inc. (Ethan Allen), incorporated in May 25, 1989, through its wholly owned subsidiary, Ethan Allen Global, Inc. and Ethan Allen Global, Inc.�� subsidiaries, is a manufacturer and retailer of home furnishings and accessories, offering a complement of home decorating and design solutions through home furnishing retail networks. The Company operates in two segments: wholesale and retail. As of June 30, 2013, the Company operated 147 design centers and its independent retailers operated 148 design centers. Its wholesale segment net sales include sales to its retail segment and sales to its independent retailers. During the fiscal year ended June 30, 2013 (fiscal 2013), independent retailers opened 11 new design centers, acquired two from the Company, closed 12, and sold two to the Company.
The Company�� customer service offerings include gift card, on-line room planning and Ethan Allen Consumer Credit Programs. Gift Card allows customers to purchase gift cards through its Website or at any participating retail design center, which can be redeemed for any of its products or services. The Company offers, through its Website, an online room planning resource, which serves to assist consumers with their home decorating needs. Through the use of this Web-based tool, customers can determine which of its product offerings fit their particular needs based on their own individual home floor plan. The Ethan Allen Finance Plus program offers consumers (clients) a menu of custom financing options through the use of just one account.
Wholesale Segment
The wholesale segment, principally involved in the development of the Ethan Allen brand, encompasses all aspects of design, manufacture, sourcing, sale, and distribution of its range of home furnishings and accessories. Wholesale revenue is generated upon the wholesale sale and shipment of its products to its network of independently operated design centers and Company-operated design centers through its na! tional distribution center and one other smaller fulfillment center. The Company�� domestic manufacturing is included in the results of the wholesale segment. The Company operates four case plants (including one sawmill), three upholstery plants (two upholstery plants on its Maiden, North Carolina campus and one cut and sew plant in Mexico) and one home accessory plant. The Company also source selected case goods, upholstery, and home accessory items from third-party suppliers located both domestically and outside the United States.
Retail Segment
The retail segment sells home furnishings and accessories to consumers through a network of Company-operated design centers. During fiscal 2013, the Company opened seven design centers acquired two from independent retailers, closed four design centers and sold two to our independent retailers. As of June 30, 2013, the Company�� network of approximately 300 retail design centers and approximately 4,000 independent members of the Interior Design Affiliate program benefit from these marketing efforts.
Advisors' Opinion:- [By Ben Levisohn]
Shares of La-Z-Boy have gained 11% to $27.02 at 1:54 p.m. today. Its performance is also giving other furniture stocks a boost. Flexsteel (FLXS) has risen 1% to $27.60, Hooker Furniture (HOFT) has jumped 1.6% to $17.12 and Ethan Allen International (ETH) has advanced 1.2% to $29.20. Haverty Furniture (HVT) has dipped 0.3% to $27.87.
5 Best Integrated Utility Stocks To Buy For 2014: Galectin Therapeutics Inc (GALT)
Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc., incorporated on January 26, 2001, is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease. As of December 31, 2011, the Company has two compounds in development, one is to be used in cancer therapy and the other intended to be used in the treatment of liver fibrosis and fatty liver disease. These two compounds are produced from different natural starting materials, both possessing the property, which lends itself to binding to and inhibiting galectin proteins. GM-CT-01, the Company's product candidate for cancer therapy, is a linear polysaccharide polymer consisted of mannose and galactose that has a defined chemical structure and is derived from a plant source. GR-MD-02, the Company's product for treatment of liver fibrosis and fatty liver disease with inflammation and fibrosis, is a polysaccharide polymer possessing both linear and globular structures, which also is derived from a plant source.
GM-CT-01 has in development for the therapy of colorectal cancer and is in a Phase I/II clinical trial as a combination therapy with a tumor vaccine in patients with advanced melanoma. Based on the completed Phase I and partially completed Phase II clinical trials, the Company is exploring two additional potential indicia for the use of GM-CT-01 in combination with cancer chemotherapy. There are two additional pathways for the development of GM-CT-01 for use in treatment of cancer. GM-CT-01 was found to be generally safe when studied in a Phase I clinical trial in end-stage cancer patients with multiple tumor types alone and in combination with 5-Fluorouracil (5-FU), which is an Food and Drug Administration (FDA)-approved chemotherapy used for treatment of various types of cancer.
Advisors' Opinion:- [By Roberto Pedone]
Galectin Therapeutics (GALT) offers drug research and development to create new therapies for fibrotic disease and cancer. This stock closed up 9.6% to $12.06 in Monday's trading session.
Monday's Volume: 674,000
Three-Month Average Volume: 222,171
Volume % Change: 149%Shares of GALT jumped higher on Monday after Ascendiant initiated coverage on the stock with a buy recommendation.
From a technical perspective, GALT spiked sharply higher here with strong upside volume. This stock has been uptrending for the last three months, with shares ripping higher from its low of $3.95 to its recent high of $13.21. During that move, shares of GALT have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GALT within range of triggering a near-term breakout trade. That trade will hit if GALT manages to take out Monday's high of $12.44 and then once it clears its 52-week high at $13.21 with high volume.
Traders should now look for long-biased trades in GALT as long as it's trending above some near-term support levels at $11 or at $10 and then once it sustains a move or close above those breakout levels with volume that hits near or above 222,171 shares. If that breakout hits soon, then GALT will set up to enter new 52-week-high territory above $13.21, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $16.
No comments:
Post a Comment